BioSpace News Archive

Supporting the printing and graphic arts industry for over 70 years, Oxytech Systems is helping companies like SG360° keep their operations running by using its ultraviolet light technology to quickly and efficiently sanitize their facilities against COVID-19.

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer is pleased to announce the acceptance of two poster presentations at the American Society of Clinical Oncology (“ASCO”) Virtual Annual Meeting, taking place virtually from May 29, 2020 to June 2, 2020. The presentat

OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the Company’s continued Double-Diamond sponsorship for the virtual 2020 Pediatric Orthopaedic Society of North America (“POSNA”) Annual Meeting, which will open online May 13, 2020 and remain available until December 31, 2020. OrthoPediatrics retains its designation as a Double Diamond S

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide a corporate update on its pharmaceutical programs for Bucillamine in the treatment of the coronavirus disease (“COVID-19”) and in the psychedelics area. “We are advancing our main programs in COVID-19 and psychedelics with the aim to initi

Pfizer Inc. announced today that it will be holding its rescheduled Investor Day on Monday, September 14, 2020 at 9:00 a.m. EDT.

Peer-Reviewed Article Validates Tack Endovascular System ® as a Clinically Important Treatment for Post-Angioplasty Dissection Repair in Above-the-Knee Complex Lesions WAYNE, Pa.--( BUSINESS WIRE )-- Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the peer-reviewed publication of its T ack O ptimized B alloon A ngioplasty (TOBA) III 12-month clinical trial

The global blood cell analyzer market depicts a highly competitive and expansive vendor landscape to exist, says Transparency Market Research on the basis of a recently published report.

Smiths Medical, a leading global medical device manufacturer, announces today the acquisition of the business of Access Scientific, LLC, a privately-held company based in San Diego, CA.

XLerateHealth (XLH), its affiliate, the Southeast XLerator Network (XLN), and XLN Academic Lead, the University of Kentucky, are pleased to announce that the National Institutes of Health (NIH) has approved XLN’s External Advisory Committee’s (EAC) recommendation to fund the continued development of seven biomedical innovations that represent various areas of technology, from medical devices to diagnostics and therapeutics.

The collaboration with CDR-Life is the second strategic partnership within a year for Boehringer Ingelheim in retinal diseases, furthering the company’s commitment to develop novel treatments and technologies for patients who have only inadequate treatment options Together the partners will advance CDR-Life’s preclinical antibody fragments targeting a key pathway in geographic atrophy (GA) INGELHEIM, Germany & SCHLIEREN, Switzerlan